GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 67 | |
SMR RATING 1..100 | 39 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 27 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EAFG | GSK | |
---|---|---|
RSI ODDS (%) | 4 days ago88% | 4 days ago46% |
Stochastic ODDS (%) | 4 days ago79% | 4 days ago46% |
Momentum ODDS (%) | 4 days ago67% | 4 days ago46% |
MACD ODDS (%) | 4 days ago73% | 4 days ago48% |
TrendWeek ODDS (%) | 4 days ago80% | 4 days ago52% |
TrendMonth ODDS (%) | 4 days ago71% | 4 days ago53% |
Advances ODDS (%) | 20 days ago79% | 6 days ago58% |
Declines ODDS (%) | N/A | 27 days ago54% |
BollingerBands ODDS (%) | 4 days ago73% | 4 days ago52% |
Aroon ODDS (%) | N/A | 4 days ago45% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPYD | 45.01 | 0.33 | +0.74% |
SPDR® Portfolio S&P 500® High Div ETF | |||
MPA | 10.82 | 0.05 | +0.46% |
Blackrock Muniyield Pennsylvania Quality Fund | |||
HSMV | 36.80 | 0.07 | +0.18% |
First Trust Horizon Managed Vol S/M ETF | |||
FLCV | 30.29 | -0.02 | -0.05% |
Federated Hermes MDT Large Cap Value ETF | |||
SDVD | 21.65 | -0.07 | -0.32% |
FT Vest SMID Ris Div Ach Trg IncETF |
A.I.dvisor tells us that EAFG and ROG have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAFG and ROG's prices will move in lockstep.
Ticker / NAME | Correlation To EAFG | 1D Price Change % | ||
---|---|---|---|---|
EAFG | 100% | N/A | ||
ROG - EAFG | 23% Poorly correlated | +0.06% | ||
RIO - EAFG | 21% Poorly correlated | -0.25% | ||
EVO - EAFG | 20% Poorly correlated | -0.28% | ||
GSK - EAFG | 20% Poorly correlated | +0.58% | ||
BHP - EAFG | 19% Poorly correlated | -0.62% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.